Amicus Therapeutics Us, Llc NDCs and Package Codes
This page lists NDC package records associated with labeler code 71904 (Amicus Therapeutics Us, Llc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
7
Package NDCs
5
Products
5
Active listings
0
Discontinued
3
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 5 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Galafold migalastat hydrochloride 123 mg/1 CAPSULE | 71904-0100-01 | — | On market | View → |
| OPFOLDA miglustat 65 mg/1 CAPSULE | 71904-0300-01 | — | On market | View → |
| POMBILITI ATGA cipaglucosidase alfa-atga 105 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 71904-0200-01 | — | On market | View → |
| POMBILITI ATGA cipaglucosidase alfa-atga 105 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 71904-0200-01 | — | On market | View → |
| POMBILITI ATGA cipaglucosidase alfa-atga 105 mg/1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 71904-0200-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.